1 / 3

Human Milk Oligosaccharides Market Overview And Growth Prediction 2013 To 2024

The global human milk oligosaccharides (HMO) market size is expected to reach USD 170.4 million by 2024. It is anticipated to expand at a CAGR of 12.3% over the forecast period.

Jitendra_Magar
Télécharger la présentation

Human Milk Oligosaccharides Market Overview And Growth Prediction 2013 To 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Your Catalyst to a Lucrative Business Human Milk Oligosaccharides Market Share, Share,Growth, Segmentation, Outlook and Forecasts to 2024 | HexaResearch “ The global human milk oligosaccharides (HMO) market size is expectedto reach USD 170.4 million by2024.” 23 January2019 The global human milk oligosaccharides (HMO) marketsize is expected to reach USD 170.4 million by 2024. It is anticipated to expand at a CAGR of 12.3% over the forecast period. HMO is a bioactive complex sugar molecule, which promotes growth of healthy bacteria, such as bifid bacteria genus in human gut. It also and helps improve metabolic activity in human body. In addition, incorporation of HMO in the formulation of functional foods and beverages not only promotes growth of healthy bacteria but also eliminates harmful microbes such as salmonella, listeria, and campylobacter. High infant mortality rate coupled with rising demand for human milk donors in North America is one of the major drivers for the HMO market. North America accounted for around 25.0% of global market share in 2015 and is projected to expand further during the forecast period. Growing demand for infant food especially for infants with non-lactating mothers coupled with strong presence of infant formula manufacturers in U.S. is expected to have a positive impact on regional market. Besides North America, Europe is one of the key markets for human milk oligosaccharides. Presence of a large biotechnical institutes engaged in the development of enzyme formulations in Germany, U.K., and France is encouraging HMO manufacturers to establish tie-ups to improve their R&Dactivities. Over the past few years, many R&D institutes have launched chemically synthesizing techniques and cow milk processing methods for the production of HMO. Extraction of human milk oligosaccharides is a bit expensive due to the limited access to raw materials. Product innovations aimed at improving brain health, are expected to pose a threat to the existing market participants. According to the World Health Organization (WHO), the world population is expected rise by over a billion in the next 10 years. This factor is anticipated to propel demand for infant food, thereby driving the global market. FollowUs:

  2. Your Catalyst to a Lucrative Business Browse Details of Report @ https://www.hexaresearch.com/research-report/human-milk-oligosaccharides-hmo- market The HMO is also useful for adults as it helps maintain health of the digestive system. The ingredient acts as a microbiota modulator and maintains health of the immune system. HMO also helps prevent T1D, which interacts between the innate immune system and intestinal microbes in adults. High demand for digestive health supplements among adults due to rising concerns regarding gastrointestinal disorders is expected to promote marketgrowth. Some of the key manufacturers in the Human Milk Oligosaccharides (HMO) market include Inbiose; Jennewein Biotechnologie GmbH; Elicityl SA; Glycom A/S; ZuChem, Inc.; Medolac Laboratories; and Glycosyn LLC. Increased number of health claims in U.S. and several developed markets ofEurope has spurred studies to explore the potential of HMO. These studies have derived differentmicrobial challenges in gut, prevention of diarrhea, and protection frominfectious diseases. In September 2013, ZuChem launched new HMO formulations including l-galactose, as well as sugarphosphates such as β-l-glucose-1-phosphate, α-d-galactose-1-phosphate, and β-l-xylose-1-phosphate. In October2014, U.S. based Madolac Laboratories completed construction of second phase ofHMO purification plant. Thisplantwillsynthesizehumanmilkoligosaccharidesonalargescale,whichwillbefurtherusedin clinical trials and scientificresearch. • Hexa Research has segmented the global human milk oligosaccharides (HMO) market report based on application andregion:- • Segmentation byApplication • InfantFormula • Functional Food &Beverages • FoodSupplements • Others • Segmentation byRegion • NorthAmerica • U.S. • Europe • U.K. • Germany • AsiaPacific • China • Japan • LatinAmerica • Brazil • MEA FollowUs:

  3. Your Catalyst to a Lucrative Business • Key playersanalyzed: • InbioseNV • ElicitylS.A. • Jennewein BiotechnologieGmbH • GlycomA/S • MedolacLaboratories • ZuChemInc. • GlycosynLLC • Browse Related Category Market Reports @https://www.hexaresearch.com/research-category/semiconductors- and-electronics-industry • AboutUs: • Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growthinitiatives. • ContactUs: • Ryan Shaw HexaResearch • Felton Office Plaza 6265 Highway9 • Felton, California 95018 UnitedStates • Phone:+1-800-489-3075 • Email:sales@hexaresearch.com • Website -https://www.hexaresearch.com FollowUs:

More Related